Michael Eisen Takes on Eric Lander and the Scientific Establishment
Michael Eisen is anything but silent. In his career as a scientist, which has included a slapdash U.S. Senate campaign, blog posts, and nearly 39,000 tweets, he has lobbed grenades at the powers that be.
The Broad Institute draws NIH funding to subsidize dozens of basic research projects, many of them conducted with commercial partners. But it is the Broad’s handling of its own CRISPR business and partnerships that threaten to undermine its nonprofit mission.